世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

夜尿症の世界市場規模、現状、予測2021-2027年

夜尿症の世界市場規模、現状、予測2021-2027年


Global Nocturia Market Size, Status and Forecast 2021-2027

市場分析とインサイト夜間頻尿の世界市場 夜尿症の世界市場規模は、2020年の2億3,658万米ドルから2027年には3億4,268万米ドルに達し、2021年から2027年の間に6.97%のCAGRで推移すると予測しています。 本レポー... もっと見る

　

　

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ 		2021年12月9日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

市場分析とインサイト夜間頻尿の世界市場
夜尿症の世界市場規模は、2020年の2億3,658万米ドルから2027年には3億4,268万米ドルに達し、2021年から2027年の間に6.97%のCAGRで推移すると予測しています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の夜尿症市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、収益面での世界の夜尿症市場全体のサイズを含む、検証された信頼できる市場予測にアクセスすることができます。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の夜尿症市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の夜尿症市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。
世界の夜尿症の範囲と市場規模
夜尿症市場は、プレイヤー別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界の夜尿症市場に参加するプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。
企業別
アステラス製薬
アラガン
フェリング・ファーマシューティカルズ
イーライリリー
グラクソ・スミスクライン（GlaxoSmithKline
サノフィ
ファイザー
アボット
テバ
マイラン
ジョンソン・エンド・ジョンソン
海南中和製薬
タイプ別セグメント
デスモプレシン
抗コリン剤
αブロッカー
利尿剤
その他
用途別セグメント
病院薬局
小売薬局
オンライン薬局
地域別
北アメリカ
アメリカ
カナダ
メキシコ

アジア太平洋
中国
日本
韓国
インド
オーストラリア
東南アジア
その他のアジア

ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他の欧州

南米
メキシコ
ブラジル
その他の南アメリカ諸国

中近東・アフリカ
中近東
アフリカ

ページTOPに戻る


目次


1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 2
1.2.1 Global Nocturia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 2
1.2.2 Desmopressin 3
1.2.3 Anticholinergic Drugs 4
1.2.4 Alpha Blockers 5
1.2.5 Diuretics 6
1.2.6 Others 6
1.3 Market by Application 7
1.3.1 Global Nocturia Market Share by Application: 2016 VS 2021 VS 2027 7
1.3.2 Hospital Pharmacies 8
1.3.3 Retail Pharmacies 9
1.3.4 Online Pharmacies 9
1.4 Study Objectives 10
1.5 Years Considered 10
2 GLOBAL GROWTH TRENDS 11
2.1 Global Nocturia Market Perspective (2016-2027) 11
2.2 Nocturia Growth Trends by Regions 12
2.2.1 Nocturia Market Size by Regions: 2016 VS 2021 VS 2027 12
2.2.2 Nocturia Historic Market Size by Regions (2016-2021) 13
2.2.3 Nocturia Forecasted Market Size by Regions (2022-2027) 14
2.3 Nocturia Industry Dynamic 15
2.3.1 Nocturia Market Trends 15
2.3.2 Nocturia Market Drivers 16
2.3.3 Nocturia Market Challenges 16
2.3.4 Nocturia Market Restraints 17
3 COMPETITION LANDSCAPE BY KEY PLAYERS 18
3.1 Global Top Nocturia Players by Revenue 18
3.1.1 Global Top Nocturia Players by Revenue (2016-2021) 18
3.1.2 Global Nocturia Revenue Market Share by Players (2016-2021) 19
3.2 Global Nocturia Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 20
3.3 Players Covered: Ranking by Nocturia Revenue 22
3.4 Global Nocturia Market Concentration Ratio 23
3.4.1 Global Nocturia Market Concentration Ratio (CR5 and HHI) 23
3.4.2 Global Top 3 and Top 5 Companies by Nocturia Revenue in 2020 24
3.5 Nocturia Key Players Head office and Area Served 25
3.6 Key Players Nocturia Product Solution and Service 25
3.7 Established Date of Key Company in Nocturia Market 26
3.8 Mergers & Acquisitions, Expansion Plans 26
4 NOCTURIA BREAKDOWN DATA BY TYPE 28
4.1 Global Nocturia Historic Market Size by Type (2016-2021) 28
4.2 Global Nocturia Forecasted Market Size by Type (2022-2027) 29
5 NOCTURIA BREAKDOWN DATA BY APPLICATION 31
5.1 Global Nocturia Historic Market Size by Application (2016-2021) 31
5.2 Global Nocturia Forecasted Market Size by Application (2022-2027) 32
6 NORTH AMERICA 34
6.1 North America Nocturia Market Size (2016-2027) 34
6.2 North America Nocturia Market Size by Type 34
6.2.1 North America Nocturia Market Size by Type (2016-2021) 34
6.2.2 North America Nocturia Market Size by Type (2022-2027) 35
6.2.3 North America Nocturia Market Share by Type (2016-2027) 35
6.3 North America Nocturia Market Size by Application 36
6.3.1 North America Nocturia Market Size by Application (2016-2021) 36
6.3.2 North America Nocturia Market Size by Application (2022-2027) 36
6.3.3 North America Nocturia Market Share by Application (2016-2027) 37
6.4 North America Nocturia Market Size by Country 37
6.4.1 North America Nocturia Market Size by Country (2016-2021) 37
6.4.2 North America Nocturia Market Share by Country (2022-2027) 38
6.4.3 United States 39
6.4.4 Canada 39
6.4.5 Mexico 40
7 EUROPE 41
7.1 Europe Nocturia Market Size (2016-2027) 41
7.2 Europe Nocturia Market Size by Type 41
7.2.1 Europe Nocturia Market Size by Type (2016-2021) 41
7.2.2 Europe Nocturia Market Size by Type (2022-2027) 42
7.2.3 Europe Nocturia Market Share by Type (2016-2027) 42
7.3 Europe Nocturia Market Size by Application 43
7.3.1 Europe Nocturia Market Size by Application (2016-2021) 43
7.3.2 Europe Nocturia Market Size by Application (2022-2027) 43
7.3.3 Europe Nocturia Market Share by Application (2016-2027) 44
7.4 Europe Nocturia Market Size by Country 44
7.4.1 Europe Nocturia Market Size by Country (2016-2021) 44
7.4.2 Europe Nocturia Market Size by Country (2022-2027) 45
7.4.3 Germany 46
7.4.4 France 46
7.4.5 U.K. 47
7.4.6 Italy 47
7.4.7 Russia 48
7.4.8 Nordic 48
8 ASIA-PACIFIC 49
8.1 Asia-Pacific Nocturia Market Size (2016-2027) 49
8.2 Asia-Pacific Nocturia Market Size by Type 49
8.2.1 Asia-Pacific Nocturia Market Size by Type (2016-2021) 49
8.2.2 Asia-Pacific Nocturia Market Size by Type (2022-2027) 50
8.2.3 Asia-Pacific Nocturia Market Share by Type (2016-2027) 50
8.3 Asia-Pacific Nocturia Market Size by Application 51
8.3.1 Asia-Pacific Nocturia Market Size by Application (2016-2021) 51
8.3.2 Asia-Pacific Nocturia Market Size by Application (2022-2027) 51
8.3.3 Asia-Pacific Nocturia Market Share by Application (2016-2027) 52
8.4 Asia-Pacific Nocturia Market Size by Region 52
8.4.1 Asia-Pacific Nocturia Market Size by Region (2016-2021) 52
8.4.2 Asia-Pacific Nocturia Market Size by Region (2022-2027) 53
8.4.3 China 54
8.4.4 Japan 54
8.4.5 South Korea 55
8.4.6 India 55
8.4.7 Australia 56
8.4.8 Southeast Asia 56
9 SOUTH AMERICA 57
9.1 South America Nocturia Market Size (2016-2027) 57
9.2 South America Nocturia Market Size by Type 57
9.2.1 South America Nocturia Market Size by Type (2016-2021) 57
9.2.2 South America Nocturia Market Size by Type (2022-2027) 58
9.2.3 South America Nocturia Market Share by Type (2016-2027) 58
9.3 South America Nocturia Market Size by Application 59
9.3.1 South America Nocturia Market Size by Application (2016-2021) 59
9.3.2 South America Nocturia Market Size by Application (2022-2027) 59
9.3.3 South America Nocturia Market Share by Application (2016-2027) 60
9.4 South America Nocturia Market Size by Country 60
9.4.1 South America Nocturia Market Size by Country (2016-2021) 60
9.4.2 South America Nocturia Market Size by Country (2022-2027) 61
9.4.3 Brazil 62
9.4.4 Argentina 62
10 MIDDLE EAST & AFRICA 63
10.1 Middle East & Africa Nocturia Market Size (2016-2027) 63
10.2 Middle East & Africa Nocturia Market Size by Type 63
10.2.1 Middle East & Africa Nocturia Market Size by Type (2016-2021) 63
10.2.2 Middle East & Africa Nocturia Market Size by Type (2022-2027) 64
10.2.3 Middle East & Africa Nocturia Market Share by Type (2016-2027) 64
10.3 Middle East & Africa Nocturia Market Size by Application 65
10.3.1 Middle East & Africa Nocturia Market Size by Application (2016-2021) 65
10.3.2 Middle East & Africa Nocturia Market Size by Application (2022-2027) 65
10.3.3 Middle East & Africa Nocturia Market Share by Application (2016-2027) 66
10.4 Middle East & Africa Nocturia Market Size by Country 66
10.4.1 Middle East & Africa Nocturia Market Size by Country (2016-2021) 66
10.4.2 Middle East & Africa Nocturia Market Size by Country (2022-2027) 67
10.4.3 Middle East 68
10.4.4 Africa 68
11 KEY PLAYERS PROFILES 69
11.1 Astellas Pharma 69
11.1.1 Astellas Pharma Company Details 69
11.1.2 Astellas Pharma Business Overview 69
11.1.3 Astellas Pharma Nocturia Introduction 70
11.1.4 Astellas Pharma Revenue in Nocturia Business (2016-2021) 71
11.1.5 Astellas Pharma Recent Development 71
11.2 Allergan 72
11.2.1 Allergan Company Details 72
11.2.2 Allergan Business Overview 72
11.2.3 Allergan Nocturia Introduction 73
11.2.4 Allergan Revenue in Nocturia Business (2016-2021) 73
11.2.5 Allergan Recent Development 73
11.3 Ferring Pharmaceuticals 74
11.3.1 Ferring Pharmaceuticals Company Details 74
11.3.2 Ferring Pharmaceuticals Business Overview 74
11.3.3 Ferring Pharmaceuticals Nocturia Introduction 75
11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2016-2021) 76
11.3.5 Ferring Pharmaceuticals Recent Development 76
11.4 Eli Lilly 77
11.4.1 Eli Lilly Company Details 77
11.4.2 Eli Lilly Business Overview 77
11.4.3 Eli Lilly Nocturia Introduction 78
11.4.4 Eli Lilly Revenue in Nocturia Business (2016-2021) 78
11.4.5 Eli Lilly Recent Development 78
11.5 GlaxoSmithKline 79
11.5.1 GlaxoSmithKline Company Details 79
11.5.2 GlaxoSmithKline Business Overview 79
11.5.3 GlaxoSmithKline Nocturia Introduction 80
11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2016-2021) 81
11.5.5 GlaxoSmithKline Recent Development 81
11.6 Sanofi 81
11.6.1 Sanofi Company Details 81
11.6.2 Sanofi Business Overview 82
11.6.3 Sanofi Nocturia Introduction 82
11.6.4 Sanofi Revenue in Nocturia Business (2016-2021) 84
11.6.5 Sanofi Recent Development 84
11.7 Pfizer 85
11.7.1 Pfizer Company Details 85
11.7.2 Pfizer Business Overview 85
11.7.3 Pfizer Nocturia Introduction 86
11.7.4 Pfizer Revenue in Nocturia Business (2016-2021) 86
11.7.5 Pfizer Recent Development 87
11.8 Abbott 87
11.8.1 Abbott Company Details 87
11.8.2 Abbott Business Overview 88
11.8.3 Abbott Nocturia Introduction 88
11.8.4 Abbott Revenue in Nocturia Business (2016-2021) 89
11.8.5 Abbott Recent Development 89
11.9 Teva 90
11.9.1 Teva Company Details 90
11.9.2 Teva Business Overview 90
11.9.3 Teva Nocturia Introduction 91
11.9.4 Teva Revenue in Nocturia Business (2016-2021) 91
11.10 Mylan 92
11.10.1 Mylan Company Details 92
11.10.2 Mylan Business Overview 92
11.10.3 Mylan Nocturia Introduction 93
11.10.4 Mylan Revenue in Nocturia Business (2016-2021) 94
11.10.5 Mylan Recent Development 94
11.11 Johnson & Johnson 95
11.11.1 Johnson & Johnson Company Details 95
11.11.2 Johnson & Johnson Business Overview 95
11.11.3 Johnson & Johnson Nocturia Introduction 96
11.11.4 Johnson & Johnson Revenue in Nocturia Business (2016-2021) 96
11.11.5 Johnson & Johnson Recent Development 96
11.12 Hainan Zhonghe Pharmaceutical 97
11.12.1 Hainan Zhonghe Pharmaceutical Company Details 97
11.12.2 Hainan Zhonghe Pharmaceutical Business Overview 97
11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction 98
11.12.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2016-2021) 99
11.12.5 Hainan Zhonghe Pharmaceutical Recent Development 99
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 100
13 APPENDIX 101
13.1 Research Methodology 101
13.1.1 Methodology/Research Approach 101
13.1.2 Data Source 104
13.2 Disclaimer 107
13.3 Author Details 108

　

ページTOPに戻る


　

Summary

Market Analysis and Insights: Global Nocturia Market
The global Nocturia market size is projected to reach US$ 3422.68 million by 2027, from US$ 2136.58 million in 2020, at a CAGR of 6.97% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nocturia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nocturia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nocturia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nocturia market.
Global Nocturia Scope and Market Size
Nocturia market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nocturia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
By Company
Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Johnson & Johnson
Hainan Zhonghe Pharmaceutical
Segment by Type
Desmopressin
Anticholinergic Drugs
Alpha Blockers
Diuretics
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Rest of Asia

Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe

South America
Mexico
Brazil
Rest of South America

Middle East & Africa
Middle East
Africa



ページTOPに戻る


Table of Contents


1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 2
1.2.1 Global Nocturia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 2
1.2.2 Desmopressin 3
1.2.3 Anticholinergic Drugs 4
1.2.4 Alpha Blockers 5
1.2.5 Diuretics 6
1.2.6 Others 6
1.3 Market by Application 7
1.3.1 Global Nocturia Market Share by Application: 2016 VS 2021 VS 2027 7
1.3.2 Hospital Pharmacies 8
1.3.3 Retail Pharmacies 9
1.3.4 Online Pharmacies 9
1.4 Study Objectives 10
1.5 Years Considered 10
2 GLOBAL GROWTH TRENDS 11
2.1 Global Nocturia Market Perspective (2016-2027) 11
2.2 Nocturia Growth Trends by Regions 12
2.2.1 Nocturia Market Size by Regions: 2016 VS 2021 VS 2027 12
2.2.2 Nocturia Historic Market Size by Regions (2016-2021) 13
2.2.3 Nocturia Forecasted Market Size by Regions (2022-2027) 14
2.3 Nocturia Industry Dynamic 15
2.3.1 Nocturia Market Trends 15
2.3.2 Nocturia Market Drivers 16
2.3.3 Nocturia Market Challenges 16
2.3.4 Nocturia Market Restraints 17
3 COMPETITION LANDSCAPE BY KEY PLAYERS 18
3.1 Global Top Nocturia Players by Revenue 18
3.1.1 Global Top Nocturia Players by Revenue (2016-2021) 18
3.1.2 Global Nocturia Revenue Market Share by Players (2016-2021) 19
3.2 Global Nocturia Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 20
3.3 Players Covered: Ranking by Nocturia Revenue 22
3.4 Global Nocturia Market Concentration Ratio 23
3.4.1 Global Nocturia Market Concentration Ratio (CR5 and HHI) 23
3.4.2 Global Top 3 and Top 5 Companies by Nocturia Revenue in 2020 24
3.5 Nocturia Key Players Head office and Area Served 25
3.6 Key Players Nocturia Product Solution and Service 25
3.7 Established Date of Key Company in Nocturia Market 26
3.8 Mergers & Acquisitions, Expansion Plans 26
4 NOCTURIA BREAKDOWN DATA BY TYPE 28
4.1 Global Nocturia Historic Market Size by Type (2016-2021) 28
4.2 Global Nocturia Forecasted Market Size by Type (2022-2027) 29
5 NOCTURIA BREAKDOWN DATA BY APPLICATION 31
5.1 Global Nocturia Historic Market Size by Application (2016-2021) 31
5.2 Global Nocturia Forecasted Market Size by Application (2022-2027) 32
6 NORTH AMERICA 34
6.1 North America Nocturia Market Size (2016-2027) 34
6.2 North America Nocturia Market Size by Type 34
6.2.1 North America Nocturia Market Size by Type (2016-2021) 34
6.2.2 North America Nocturia Market Size by Type (2022-2027) 35
6.2.3 North America Nocturia Market Share by Type (2016-2027) 35
6.3 North America Nocturia Market Size by Application 36
6.3.1 North America Nocturia Market Size by Application (2016-2021) 36
6.3.2 North America Nocturia Market Size by Application (2022-2027) 36
6.3.3 North America Nocturia Market Share by Application (2016-2027) 37
6.4 North America Nocturia Market Size by Country 37
6.4.1 North America Nocturia Market Size by Country (2016-2021) 37
6.4.2 North America Nocturia Market Share by Country (2022-2027) 38
6.4.3 United States 39
6.4.4 Canada 39
6.4.5 Mexico 40
7 EUROPE 41
7.1 Europe Nocturia Market Size (2016-2027) 41
7.2 Europe Nocturia Market Size by Type 41
7.2.1 Europe Nocturia Market Size by Type (2016-2021) 41
7.2.2 Europe Nocturia Market Size by Type (2022-2027) 42
7.2.3 Europe Nocturia Market Share by Type (2016-2027) 42
7.3 Europe Nocturia Market Size by Application 43
7.3.1 Europe Nocturia Market Size by Application (2016-2021) 43
7.3.2 Europe Nocturia Market Size by Application (2022-2027) 43
7.3.3 Europe Nocturia Market Share by Application (2016-2027) 44
7.4 Europe Nocturia Market Size by Country 44
7.4.1 Europe Nocturia Market Size by Country (2016-2021) 44
7.4.2 Europe Nocturia Market Size by Country (2022-2027) 45
7.4.3 Germany 46
7.4.4 France 46
7.4.5 U.K. 47
7.4.6 Italy 47
7.4.7 Russia 48
7.4.8 Nordic 48
8 ASIA-PACIFIC 49
8.1 Asia-Pacific Nocturia Market Size (2016-2027) 49
8.2 Asia-Pacific Nocturia Market Size by Type 49
8.2.1 Asia-Pacific Nocturia Market Size by Type (2016-2021) 49
8.2.2 Asia-Pacific Nocturia Market Size by Type (2022-2027) 50
8.2.3 Asia-Pacific Nocturia Market Share by Type (2016-2027) 50
8.3 Asia-Pacific Nocturia Market Size by Application 51
8.3.1 Asia-Pacific Nocturia Market Size by Application (2016-2021) 51
8.3.2 Asia-Pacific Nocturia Market Size by Application (2022-2027) 51
8.3.3 Asia-Pacific Nocturia Market Share by Application (2016-2027) 52
8.4 Asia-Pacific Nocturia Market Size by Region 52
8.4.1 Asia-Pacific Nocturia Market Size by Region (2016-2021) 52
8.4.2 Asia-Pacific Nocturia Market Size by Region (2022-2027) 53
8.4.3 China 54
8.4.4 Japan 54
8.4.5 South Korea 55
8.4.6 India 55
8.4.7 Australia 56
8.4.8 Southeast Asia 56
9 SOUTH AMERICA 57
9.1 South America Nocturia Market Size (2016-2027) 57
9.2 South America Nocturia Market Size by Type 57
9.2.1 South America Nocturia Market Size by Type (2016-2021) 57
9.2.2 South America Nocturia Market Size by Type (2022-2027) 58
9.2.3 South America Nocturia Market Share by Type (2016-2027) 58
9.3 South America Nocturia Market Size by Application 59
9.3.1 South America Nocturia Market Size by Application (2016-2021) 59
9.3.2 South America Nocturia Market Size by Application (2022-2027) 59
9.3.3 South America Nocturia Market Share by Application (2016-2027) 60
9.4 South America Nocturia Market Size by Country 60
9.4.1 South America Nocturia Market Size by Country (2016-2021) 60
9.4.2 South America Nocturia Market Size by Country (2022-2027) 61
9.4.3 Brazil 62
9.4.4 Argentina 62
10 MIDDLE EAST & AFRICA 63
10.1 Middle East & Africa Nocturia Market Size (2016-2027) 63
10.2 Middle East & Africa Nocturia Market Size by Type 63
10.2.1 Middle East & Africa Nocturia Market Size by Type (2016-2021) 63
10.2.2 Middle East & Africa Nocturia Market Size by Type (2022-2027) 64
10.2.3 Middle East & Africa Nocturia Market Share by Type (2016-2027) 64
10.3 Middle East & Africa Nocturia Market Size by Application 65
10.3.1 Middle East & Africa Nocturia Market Size by Application (2016-2021) 65
10.3.2 Middle East & Africa Nocturia Market Size by Application (2022-2027) 65
10.3.3 Middle East & Africa Nocturia Market Share by Application (2016-2027) 66
10.4 Middle East & Africa Nocturia Market Size by Country 66
10.4.1 Middle East & Africa Nocturia Market Size by Country (2016-2021) 66
10.4.2 Middle East & Africa Nocturia Market Size by Country (2022-2027) 67
10.4.3 Middle East 68
10.4.4 Africa 68
11 KEY PLAYERS PROFILES 69
11.1 Astellas Pharma 69
11.1.1 Astellas Pharma Company Details 69
11.1.2 Astellas Pharma Business Overview 69
11.1.3 Astellas Pharma Nocturia Introduction 70
11.1.4 Astellas Pharma Revenue in Nocturia Business (2016-2021) 71
11.1.5 Astellas Pharma Recent Development 71
11.2 Allergan 72
11.2.1 Allergan Company Details 72
11.2.2 Allergan Business Overview 72
11.2.3 Allergan Nocturia Introduction 73
11.2.4 Allergan Revenue in Nocturia Business (2016-2021) 73
11.2.5 Allergan Recent Development 73
11.3 Ferring Pharmaceuticals 74
11.3.1 Ferring Pharmaceuticals Company Details 74
11.3.2 Ferring Pharmaceuticals Business Overview 74
11.3.3 Ferring Pharmaceuticals Nocturia Introduction 75
11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2016-2021) 76
11.3.5 Ferring Pharmaceuticals Recent Development 76
11.4 Eli Lilly 77
11.4.1 Eli Lilly Company Details 77
11.4.2 Eli Lilly Business Overview 77
11.4.3 Eli Lilly Nocturia Introduction 78
11.4.4 Eli Lilly Revenue in Nocturia Business (2016-2021) 78
11.4.5 Eli Lilly Recent Development 78
11.5 GlaxoSmithKline 79
11.5.1 GlaxoSmithKline Company Details 79
11.5.2 GlaxoSmithKline Business Overview 79
11.5.3 GlaxoSmithKline Nocturia Introduction 80
11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2016-2021) 81
11.5.5 GlaxoSmithKline Recent Development 81
11.6 Sanofi 81
11.6.1 Sanofi Company Details 81
11.6.2 Sanofi Business Overview 82
11.6.3 Sanofi Nocturia Introduction 82
11.6.4 Sanofi Revenue in Nocturia Business (2016-2021) 84
11.6.5 Sanofi Recent Development 84
11.7 Pfizer 85
11.7.1 Pfizer Company Details 85
11.7.2 Pfizer Business Overview 85
11.7.3 Pfizer Nocturia Introduction 86
11.7.4 Pfizer Revenue in Nocturia Business (2016-2021) 86
11.7.5 Pfizer Recent Development 87
11.8 Abbott 87
11.8.1 Abbott Company Details 87
11.8.2 Abbott Business Overview 88
11.8.3 Abbott Nocturia Introduction 88
11.8.4 Abbott Revenue in Nocturia Business (2016-2021) 89
11.8.5 Abbott Recent Development 89
11.9 Teva 90
11.9.1 Teva Company Details 90
11.9.2 Teva Business Overview 90
11.9.3 Teva Nocturia Introduction 91
11.9.4 Teva Revenue in Nocturia Business (2016-2021) 91
11.10 Mylan 92
11.10.1 Mylan Company Details 92
11.10.2 Mylan Business Overview 92
11.10.3 Mylan Nocturia Introduction 93
11.10.4 Mylan Revenue in Nocturia Business (2016-2021) 94
11.10.5 Mylan Recent Development 94
11.11 Johnson & Johnson 95
11.11.1 Johnson & Johnson Company Details 95
11.11.2 Johnson & Johnson Business Overview 95
11.11.3 Johnson & Johnson Nocturia Introduction 96
11.11.4 Johnson & Johnson Revenue in Nocturia Business (2016-2021) 96
11.11.5 Johnson & Johnson Recent Development 96
11.12 Hainan Zhonghe Pharmaceutical 97
11.12.1 Hainan Zhonghe Pharmaceutical Company Details 97
11.12.2 Hainan Zhonghe Pharmaceutical Business Overview 97
11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction 98
11.12.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2016-2021) 99
11.12.5 Hainan Zhonghe Pharmaceutical Recent Development 99
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 100
13 APPENDIX 101
13.1 Research Methodology 101
13.1.1 Methodology/Research Approach 101
13.1.2 Data Source 104
13.2 Disclaimer 107
13.3 Author Details 108

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630